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SerotoninWhether leptin targets the hypothalamic serotonergic system to inhibit food intake is not established. We
examined the effect of a short-term i.c.v. leptin treatment on serotonin microdialysate levels in rat lateral
hypothalamus. Adipose tissue gene expression was also evaluated.
Male rats received four daily injections of leptin (5 μg) or vehicle (with pair-feeding to leptin-induced intake)
and a ﬁfth injection during collection of LH microdialysates. We found that serotonin and 5-HIAA levels were
not affected by the leptin pre-treatment, as basal levels were similar between the leptin and the pair-fed
group. These levels remained unaltered after the acute leptin injection.
For gene expression studies, rats were pre-treated with ﬁve daily injections of either leptin (5 μg) or vehicle
(with either pair-feeding or ad libitum intake). mRNA levels of resistin, adiponectin, lipoprotein lipase, and
PPAR-gamma were unaltered by either leptin or pair-feeding. Leptin gene expression was signiﬁcantly re-
duced by leptin but not by pair-feeding, in both the retroperitoneal (−74%) and the epididymal (−99%) de-
pots while no differences were observed in the subcutaneous depot.
The observations conﬁrmed the absence of an acute stimulatory effect of central leptin on serotonin release in
the lateral hypothalamus and showed that the pre-treatment with leptin failed to modify this pattern. This
indicates that components of the serotonergic system are probably not directly affected by leptin. Addition-
ally, the central effect of leptin was able to downregulate its own adipose tissue gene expression in a
depot-speciﬁc manner while other adipokine genes were not affected.
© 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
It is well recognized that the adipocyte hormone leptin plays a
pivotal role in signaling to the central nervous system (CNS) infor-
mation about the amount of energy stored in white adipose tissue
(WAT), thus inﬂuencing the central mechanisms involved in the
maintenance of energy balance. This effect results, at least in part,
from the stimulatory effect of leptin on central anorexigenic factors
such as proopiomelanocortin (POMC), cocaine- and amphetamine-
regulated transcript (CART), and neurotensin, with a concomitant
inhibitory effect on central orexigenic factors such as neuropeptide
Y (NPY), agouti related peptide (AgRP), melanin-concentrating hor-
mone (MCH) and orexins [1,2].
The neurotransmitter serotonin has catabolic effects on energy
homeostasis, reducing food intake and body weight and stimulating
energy expenditure [3–6]. Several lines of studies have examined aaulo, UNIFESP, Departamento de
no, São Paulo, SP 04023-062,
ro).
vier OA license.putative role of serotonin as one catabolic system targeted by leptin,
thus contributing to leptin hypophagia. The results are so far highly
inconclusive.
Serotonergic raphe neurons have been shown to lack the long iso-
form of leptin receptors (Ob-Rb) [7] and serotonin turnover was un-
affected in several brain areas of normal rats after 3 days of
intraperitoneal leptin infusion [8]. Basal and potassium-stimulated
serotonin overﬂow were unaltered by the addition of leptin to syn-
aptosomes or superfusion preparations of rat hypothalami [9,10].
These ﬁndings indicated that leptin did not induce serotonergic
stimulation.
However, opposite results have been reported. Serotonin raphe
neurons have been found to express Ob-Rb [11–14], peripheral leptin
has been shown to activate Ob-Rb signal transduction in brainstem
and lateral hypothalamic sites [15,16], and leptin has been shown to
stimulate hypothalamic serotonin turnover [17,18]. These data favor
a stimulatory role of leptin on the serotonergic system.
Functional studies have also led to contradictory ﬁndings, as leptin
hypophagia has been found to involve activation of 5-HT2B and
5-HT2C receptors [19,20] while it reportedly failed to be affected
after serotonergic depletion or 5-HT2C receptor knockout [21].
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jection failed to “per se” alter serotonin extracellular levels in the lateral
hypothalamus (LH)while it exacerbated the feeding-induced serotonin
levels. These ﬁndings suggested that, rather than interacting directly
with components of the serotonergic system, leptin probably targeted
the mechanisms involved in the serotonergic-stimulating effect of
food [22].
In view of the controversial ﬁndings mentioned above, we
performed the present study with the objective of investigating further
the ability of leptin to interact with the serotonergic system. To speciﬁ-
cally evaluate whether a series of repeated leptin central injections
would evidence an effect independent of food intake, we measured ex-
tracellular levels of 5-HT and its metabolite 5-hidroxyindolacetic acid,
in the lateral hypothalamus of rats pre-treated with leptin or vehicle
for 4 days. We chose the in vivo brain microdialysis technique, which
allows a direct measurement of 5-HT extracellular levels in the awake
animal.
Besides the central effect of leptin on neurotransmitters and neuro-
peptides involved in energy balance, it has been postulated that central
leptin alsomodulatesWAT activity. A recent study demonstrated that a
7-day central leptin infusion up-regulated WAT mRNA and protein
levels of resistin but failed tomodify resistin plasma levels [23]. In addi-
tion, it has been demonstrated that leptin inhibited its own expression
in adipocytes via beta 3 adrenoceptor-mediated sympathetic activity
[24]. These ﬁndings agree with other studies showing that the central
effect of leptin onWAT activity or metabolism occurred via the sympa-
thetic nervous system [25–27]. It is possible that central leptin modu-
lates WAT gene expression of other adipokines involved in energy
metabolism.
Additional experiments were then performed to evaluate the ef-
fect of the leptin treatment on leptin, adiponectin, resistin, PPARγ
and lipoprotein lipase gene expressions, in epididymal, retroperitone-
al and subcutaneous depots of white adipose tissue.
2. Materials and methods
2.1. Animals and surgery
The Committee on Animal Research Ethics of the Federal University
of São Paulo approved the procedures used in the present experiments.
Since weaning, male Wistar rats were housed ﬁve per cage and
maintained in controlled conditions of lighting (12 h light: 12 h dark)
and temperature (24 ± 1 °C), with free access to standard balanced
rat chow (4% fat, 22% protein, Nuvital Nutrients, Columbo, PR, Brazil)
and water.
At 12 to 14 weeks of age the animals used for microdialysis experi-
ments were anesthetized with ketamine/xylaxine (67/13 mg/kg) and
stereotaxically [28] implanted with both a 21-gauge guide cannula
aimed at the right lateral hypothalamus (A −2.5 mm, L −1.6 mm, V
−7.7 mm frombregma) and a 23-gauge cannula aimed at the left later-
al ventricle (A−0.9 mm, L +1.6 mm, V−2.6 mm from bregma). For
the animals used for northern blotting experiments, a single brain can-
nula was implanted, aimed at the left lateral ventricle. The cannulas
were secured to the skull with screws and dental cement and the ani-
mals were individually caged thereafter.
2.2. Microdialysis experiments
Four days after surgery, the animals were divided in 2 groups. The
leptin group received 4 daily i.c.v. injections (5 μL) of 5.0 μg of leptin
and was fed ad libitum. The pair-fed control group consisted of ani-
mals receiving 4 daily i.c.v. injections of vehicle (CSF, artiﬁcial cere-
brospinal ﬂuid) and being pair-fed to the leptin animals. Food
intake was recorded 24 h after each injection and body weight was
recorded 24 h after the ﬁrst 3 injections. The injectionswere performed
around noon.At 18:00 h, after the fourth injection, a concentric custom-constructed
microdialysis probe (1.5 mmof effectivemembrane length)was inserted
through the hypothalamic cannula and ﬁxed to it with a small drop of
dental cement. The details of probe construction have beenpreviously de-
scribed [29,30]. The animals were then connected to a swivel system,
which allowed continuous probe perfusion with CSF by amicroperfusion
pump (CarnegieMedicin, Solna, Sweden). CSF compositionwas: 145 mM
NaCl, 2.7 mM KCl, 1.0 mM MgCl2, 1.2 mM CaCl2, 2.0 mM Na2HPO4,
pH 7.4. Overnight perfusion was performed at 1.0 μL/min.
At 6:00 h, probe ﬂow rate was adjusted to 2.5 μL/min and food was
withdrawn from the cage, so that the animals were fasted for 6 h before
the microdialysis experiments. Collection of 20-min dialysate samples
was started around noon. Samples were collected into 10 μL of 0.5 M
perchloric acid and immediately injected into an HPLC system. Baseline
sampleswere collected until 5-HT levelswere stable, the last three sam-
ples being averaged to yield the mean baseline level (100% value). 5 μL
of CSF vehicle was then injected through the i.c.v. cannula and three ad-
ditional samples were collected (samples V1–V3). An i.c.v. injection of
5 μg of leptin was then administered to all animals. Nine additional
20-min dialysate samples were collected (samples L1–L9). No food
was provided during microdialysate sampling.
2.3. HPLC analysis
Dialysate levels of 5-HT and 5-HIAA were measured by high per-
formance liquid chromatography with electrochemical detection.
The system (ESA Inc., Chelmsford, Mass.) consisted of a model 580
pump with two PEEK pulse dampers in series, a 50 μL Rheodyne
PEEK sample loop, a 3 μm MD150 C column, a model 5020 guard
cell set at 300 mV, a model 5014B analytical cell set at −175 and
150 mV, and a model 5200A detector. The mobile phase consisted
of 75 mM sodium phosphate, 1.5 mM octanesulfonic acid, 50 μM
EDTA, 100 μL/L triethylamine, and 10% v/v acetonitrile at pH 3.0.
The ﬂow rate was 0.6 mL/min. The detection limit for 5-HT was
1.5 pg/50 μL at a signal to noise ratio of 3:1.
2.4. Histological analysis
For veriﬁcation of microdialysis membrane and i.c.v. cannula posi-
tioning, at the termination of the experiments all animals were deeply
anesthetized and perfused with 0.9% saline followed by 10% formalin
and 40 μmbrain sectionswere examined under amicroscope, following
staining with Cresyl Violet. Only data from rats with correct probe and
cannula placements were included in the analysis.
2.5. Northern blotting analysis
Three groups were performed for northern blot experiments. One
group received 6 daily i.c.v. injections (5 μL) of 5.0 μg of leptin and
was fed ad libitum (leptin group). Two control groups were performed,
consisting of animals receiving 6 daily i.c.v. injections of vehicle (CSF, ar-
tiﬁcial cerebrospinal ﬂuid) and either fed ad libitum (Ad libitum group)
or pair-fed to the leptin rats (pair-fed group). The injections were
performed around noon. After the ﬁfth injection, at 6:00 a.m., food
was withdrawn and, at noon, the sixth injection was administered.
One hour later, the animals were anesthetized, killed by decapitation,
and samples from epididymal, retroperitoneal and subcutaneous
white adipose tissue depots were quickly removed and inserted into
vials containing RNA later® (Ambion) and frozen at −70 °C. RNA ex-
traction was performed according to the method described by [31].
AdipokinesmRNA levels weremeasured byNorthern blotting using an-
tisense oligonucleotide probes in conjunction with chemiluminescence
detection [32]. Signals were collected by exposure of the membrane to
X-ray ﬁlm and autoradiographs were quantitated by densitometry
with image-analysis software (MCID Basic Software—Image Research
Inc.).
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– leptin: 5′-GGTCTGCGGCAGGGAGCAGCTCTTGGAGAAGGC-3′
– adiponectin: 5′-GTTGCAGTGGAATTTGCCAGTGCTGCCGTCA-3′
– resistin: 5′-CGGACGTCCCATGAGCCACAGCCAGAGCCA-3′
– lipoprotein lipase: 5′-GCCAGCAGCATGGGCTCCAAGGCTGTACCC-3′
– PPAR γ: 5′-CACGTTCAGCAAGCCTGGGCGGTCTCCACT-3′
– 18S rRNA: 5′-CGCCTGCTGCCTTCCTTGGATGTGGTAGCCG.2.6. Statistical analysis
The results are given asMeans ± S.E.M. 5-HT and 5-HIAA data were
expressed as percentage of the mean baseline microdialysate level of
each animal. The datawere submitted to ANOVA for repeatedmeasures
followed by Tukey's post hoc test, for comparisons among the samples
collected throughout the experimental period, in the same group. For
comparison between pair-fed and leptin groups, in the same sample,
the Student's t-test was used. Northern Blotting data were expressed
as densitometric arbitrary units of target mRNA/18S rRNA signal ratio.
The datawere submitted to KruskalWallis analysis of variance followed
by Dunn's post hoc test. Signiﬁcance was set at p b 0.05.
3. Results
3.1. Microdialysis experiments
Brain histological analysis showed that themicrodialysismembranes
were correctly positioned in the LH, ranging from −2.3 to −2.8 mm
from bregma, in the 11 rats analyzed in the present study (Fig. 1).
Fig. 2 shows that daily food intake was similar between the pair-fed
and the leptin groups throughout the treatment period. After 4 daily
leptin injections, the mean food intake (12.2 ± 3.3 g) tended to be
lower than that after the ﬁrst injection (20.4 ± 2.1 g), but no statistical
signiﬁcance was reached (p = 0.246). Body weight gain was alsoBregma -
Fig. 1. Drawing of a coronal section of the rat brain (from Paxinos andWatson [28]) showing
experiments.similar between the pair-fed and the leptin rats, both showing weight
loss during treatments.
Baseline levels of 5-HT and 5-HIAA in LHmicrodialysateswere similar
between leptin and pair-fed groups (Table 1). Fig. 3 shows 5-HT and
5-HIAA levels in 20-min. LH microdialysate samples collected at baseline
and after the injection of CSF-vehicle or leptin. It can be seen that 5-HT
levels failed to be signiﬁcantly modiﬁed by either injection in leptin-
treated (F(12,75) = 0.029) or vehicle-treated pair-fed rats (F(12,62) =
0.273). 5-HIAA levels were not modiﬁed after leptin injection in either
group, i.e., the pre-treated with leptin (F(12,77) = 0.156) or the pair-fed
group (F(12,64) = 0.104).
3.2. Gene expression experiments
Fig. 4 shows that the daily food intakes were similar between the
pair-fed and the leptin groups, except at day 4. Leptin inhibited food
intake since the second injection day, with a maximal 54% reduction
occurring at day 5. Body mass gain was similar among the groups at
days 1, 2, and 3. At day 4, the pair-fed and leptin animals had signif-
icantly lower body mass gain that of the ad libitum group.
Fig. 5 shows that the short-term leptin i.c.v. treatment led to re-
duction of leptin gene expression in both epididymal (99%) and retro-
peritoneal (74%) adipose tissue depots in comparison to either ad
libitum or pair-fed groups, but failed to do so in the subcutaneous
depot (χ2 = 0.961; p = 0.634). No signiﬁcant differences were ob-
served between ad libitum and pair-fed rats. Gene expression of
adiponectin, resistin, LPL, and PPARγ were similar among the groups
in all tissues (data not shown).
4. Discussion
Theﬁrst aim of the present studywas to evaluate the effect of a short
pre-treatment with leptin on the LH serotonin extracellular levels
induced by an acute leptin injection. During the pre-treatment2.56 mm
the position of the microdialysis membranes in the LH of the 11 rats used in the present
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group was thus adjusted to match this effect.
Basal levels of both serotonin and 5-HIAA in LH microdialysates
were similar between the leptin pre-treated and the pair-fed animals.
Data about the effect of feeding status on the serotonergic system are
controversial. We have previously reported that the ingestion of food
acutely stimulated the serotonergic system in the LH of normal rats,
in relation to fasting levels [22,29,33]. Serotonin release from rat
raphe tissue in vitro has been shown to be unchanged after 48 h of
fasting but enhanced after 72 h [34] while a 72-hour fast failed to
change rat brain serotonin turnover [8]. Some studies have associated
partial food restriction with lowering of central serotonergic activity,
such as decreased hypothalamic 5-HT turnover in rats and decreased
brain L-tryptophan availability in dieting human females [35,36]. In
light of these observations, it is possible that the pair-feeding regimen
used in the present study caused a reduction in baseline serotonergic
activity and that leptin failed to further modify this effect.
After the collection of basal microdialysates, both the leptin
pre-treated and the vehicle pre-treated animals received one i.c.v. in-
jection of vehicle. Serotonin levels remained stable in the three
microdialysate samples collected after vehicle injection. This present
observation in previously food-restricted (pair-fed) rats agrees with
that from our early work, in which 5-HT also remained stable in ad
libitum fed rats [22].
We next evaluated whether one leptin i.c.v. injection would acute-
ly affect the LH serotonergic activity. We failed to observe alterationsTable 1
Mean basal dialysate levels of 5-HT (pg/50 μL) and 5-HIAA (ng/50 μL) of leptin-treated
(n = 6) and pair-fed animals (n = 5). Values are means ± S.E.M.
5-HT (pg/50 μL) 5-HIAA (ng/50 μL)
Leptin 2.55 ± 0.75 3.70 ± 1.03
Pair-fed 3.39 ± 0.58 4.14 ± 1.03in either serotonin or 5-HIAA levels, regardless that the animals had
been pre-treated with leptin or vehicle for 4 days. The results ob-
served in the pair-fed group conﬁrm our previous results in ad
libitum rats in which one single i.c.v injection of leptin failed to affect
hypothalamic 5-HT release [22]. Since we have previously been able
to detect shifts in 5-HT extracellular levels in response to different
treatments, using the same methodological settings as used in the
present experiments [4,22,29,33,37], it is assured that the present ob-
servation is of physiological signiﬁcance.
Some lines of evidence indicated that serotonin could be one cat-
abolic system directly targeted by leptin while other data pointed to a
lack of such an interaction. For example, serotonin neurons of the
mesencephalic raphe nuclei have been found to express leptin recep-
tors [11–13] but Ob-Rb reportedly did not co-localize with serotonin
in dorsal raphe neurons [21]. Additionally, serotonin release by rat
synaptosomes or superfused hypothalami were unaltered by the ad-
dition of leptin [9,10] and serotonin turnover was unaffected in sever-
al brain areas of normal rats after 3 days of constant intraperitoneal
leptin infusion [8]. On the other hand, chronic i.c.v. leptin decreased
serotonin transporter binding sites in the frontal cortex, although
not in the raphe nuclei [38]. Moreover, down regulation of dorsal
raphe serotonin transporter expression has been associated with lep-
tin deﬁciency [39].
We have previously observed that, while not able to per se modify
serotonin extracellular levels in the rat LH, one leptin central injection
caused an exacerbation of the feeding-induced serotonin release,
probably by interacting with other mechanisms linking feeding to
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leptin hypophagia, although leptin affected the serotonin system
probably via indirect mechanisms [22]. In the present study, after a
series of repeated injections, we failed to ﬁnd evidence supporting
the existence of leptin's effects on serotonergic function independent
of food intake, at least reﬂected in LH extracellular levels.
Central leptin actions have been shown to include a modulation of
white adipose tissue function. In the present study, we evaluated
whether the short term i.c.v. leptin treatment was able to modify
white adipose tissue expression of genes involved in the maintenance
of energy balance and/or regulation of metabolism.
We found leptin gene expression to be reduced by central leptin in
both the retroperitoneal and the epididymal adipose tissue depots.
These ﬁndings agree with previous data [25,27] and support the sug-
gestion that, at least in these depots, a homeostatic mechanism may
be operative to control central leptin activity by negative feedback.
That this was a depot-speciﬁc effect was indicated by the lack of
an effect on leptin gene expression in the subcutaneous depot, simi-
larly to previous work [40]. It is interesting that several studies have
found the subcutaneous depot to present a different response in rela-
tion to the other depots analyzed, with respect to gene expression
proﬁle in obese individuals, depot size in growth-restricted newborn
infants and fasting effect in rats [40–42].
The effects of central leptin on adipose tissue metabolism have
been proposed to be mediated by the sympathetic nervous system,
based on several lines of evidence, including the demonstrations
that fat pad denervation or β3-adrenergic receptors gene knockout
or dopamine β-hydroxilase gene knockout abolished central leptin
effects on lipogenic enzymes and on ob gene expression in WAT
[25–27]. Moreover, the lack of a rapid effect of intraperitoneal leptin
has been taken as to suggest an indirect mechanism for the
downregulation by leptin of its own gene expression in WAT [43].Alternatively, central leptin-induced downregulation of ob gene
expression in white adipose tissue could have resulted from a direct
effect on the tissue, after leakage of leptin to the systemic circulation
during the six daily intracerebroventricular injections performed, of
5 μg/rat/day. Although we did not determine serum leptin levels,
other authors have reported that i.c.v. leptin failed to modify these
levels after dosages higher than the one used in the present study. In-
deed, it has been shown that leptin infusion in the lateral cerebral
ventricle of rats, at the dosage of 12 μg/day per 4 days, failed to in-
crease serum leptin levels, indicating no leakage of the hormone
into the circulating blood [44]. These ﬁndings corroborate the notion
that, rather than a direct stimulation of WAT leptin receptors, the re-
sults of the present experiments are likely to reﬂect an indirect action
of leptin.
Our results have also shown that central leptin failed to modify
adiponectin, LPL, resistin and PPARγ gene expression. Available data
about leptin effects on these adipose tissue genes are limited and
conﬂicting. Epididymal fat expression of resistin and adiponectin
80 M.M. Telles et al. / Regulatory Peptides 184 (2013) 75–80was unaffected while subcutaneous fat resistin but not adiponectin
expression was diminished after 4 daily peripheral leptin injections
[40]. Epididymal but not retroperitoneal fat expression of resistin
was increased after 7 daily central leptin injections [23]. Further stud-
ies are warranted in order to clarify the role of central leptin on these
white adipose tissue genes.
In summary, the present data conﬁrmed previous data showing
that leptin per se did not have an acute stimulatory effect on seroto-
nin release in the lateral hypothalamus and extended the ﬁndings to
demonstrate that the pre-treatment with the protein did not modify
this pattern. Additionally, the central effect of leptin was able to mod-
ulate its own adipose tissue gene expression in a depot-speciﬁc man-
ner while other adipokine genes were not affected.
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